Stay updated with breaking news from Suzanne Hendrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, ON (PRWEB) June 20, 2023 -- The Global Alzheimer's Platform Foundation (GAP) is delighted to announce a collaborative, free webinar focusing on the
Nearly half of some 200 mild-to-moderate Alzheimer’s patients treated with oral simufilam for one year showed gains in cognitive tests.
Cassava Sciences released data for over 200 patients in an open-label trial at 12 months. The mild AD subgroup performed unprecedentedly. See the outlook here.
Cassava Sciences, Inc. announced positive top-line Phase 2 results for simufilam, its oral drug candidate for Alzheimer's disease dementia. This was an open-label safety study with exploratory... | January 25, 2023
Elementary music educator, professor of voice, opera singer—Suzanne Hendrix-Case has done it all! And now she can add a new title: Grammy-nominated singer.